About UsUnderstanding AMLInterviewsGlobal NetworkGet InvolvedStoriesResources

Why is genetic testing key following an AML diagnosis?

Jeffrey Lancet

January 6, 2021

During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, Know AML spoke to Jeffrey Lancet, Moffitt Cancer Center, Tampa, US. We asked, Why is genetic testing key following an acute myeloid leukemia diagnosis? Lancet explains the reasons why genetic testing is so important at the time of acute myeloid leukemia diagnosis. He underlines three main reasons: prognostic purposes, choice of the initial therapy, and disease tracking.